Targeting histone deacetylase 1 (HDAC1) in the bone marrow stromal cells revers imatinib resistance by modulating IL-6 in Ph + acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting histone deacetylase 1 (HDAC1) in the bone marrow stromal cells revers imatinib resistance by modulating IL-6 in Ph + acute lymphoblastic leukemia

Published:2024-06-07 Issue:8 Volume:103 Page:3015-3027
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Wei Danna,Liang Xiaoling,Huang Meiling,Wang Caili,Ye Zhangmin,Zhang Tianzhuo,Zhang Jingrong

Funder

Guizhou Province Health Committee

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05830-9.pdf

Reference48 articles.

1. Faderl S, Jeha S, Kantarjian HM (2003) The biology and therapy of adult acute lymphoblastic leukemia. Cancer 98:1337–1354

2. Thomas DA (2007) Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challenges, Hematology. American Society of Hematology. Educ Program, 435–443

3. Thomas X, Heiblig M (2016) Diagnostic and treatment of adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematologic Oncol 5:77–90

4. Koo HH (2011) Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood. Korean J Pediatr 54:106–110

5. Trela E, Glowacki S, Błasiak J (2014) Therapy of chronic myeloid leukemia: twilight of the imatinib era? ISRN oncology, 596483

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP